2012•Journal of Modern Clinical MedicineRequires access

The Research of Terazosin Hydrochloride Combined with Diclofenac Sodium in Treatment of CP / CPPS

Yong Xu

Open publisher page 0 citations

Abstract

Objective:To compare terazosin monotherapy with terazosin plus diclofenac in treatment of chronic prostatitis/chronic pelvic pain syndromes(CP/CPPS) following initial randomness.Methods:Patients(n=106) who were diagnosed with CP/CPPS were randomly assigned to treatment with terazosin at 2 mg(group A),terazosin at 2 mg plus diclofenac at 25 mg(group B) daily.National Institutes of Health-Chronic Prostatitis Symptom Index(NIH-CPSI),subscores and the International Prostate Symptom Score(IPSS) were used to evaluate 104 patients who were treated for 8 weeks(2 withdrew).Results:The two groups all showed statistically difference before and after treatment,decreased in NIH-CPSI score,subscore and IPSS(P0.05).There were no statistically differences between the two groups.Conclusion:Terazosin monotherapy for 8 weeks is effective for treating patients with CP/CPPS same as with diclofenac.

About this research paper

What this paper is about

Objective:To compare terazosin monotherapy with terazosin plus diclofenac in treatment of chronic prostatitis/chronic pelvic pain syndromes(CP/CPPS) following initial randomness.Methods:Patients(n=106) who were diagnosed with CP/CPPS were randomly assigned to treatment with terazosin at 2 mg(group A),terazosin at 2 mg plus diclofenac at 25 mg(group B) daily.National Institutes of Health-Chronic Prostatitis Symptom Index(NIH-CPSI),subscores and the International Prostate Symptom Score(IPSS) were used to evaluate 104 patients who were treated for 8 weeks(2 withdrew).Results:The two groups all showed statistically difference before and after treatment,decreased in NIH-CPSI score,subscore and IPSS(P0.05).There were no statistically differences between the two groups.Conclusion:Terazosin monotherapy for 8 weeks is effective for treating patients with CP/CPPS same as with diclofenac.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To compare terazosin monotherapy with terazosin plus diclofenac in treatment of chronic prostatitis/chronic pelvic pain syndromes(CP/CPPS) following initial randomness.Methods:Patients(n=106) who were diagnosed with CP/CPPS were randomly assigned to treatment with terazosin at 2 mg(group A),terazosin at 2 mg plus diclofenac at 25 mg(group B) daily.National Institutes of Health-Chronic Prostatitis Symptom Index(NIH-CPSI),subscores and the International Prostate Symptom Score(IPSS) were used to evaluate 104 patients who were treated for 8 weeks(2 withdrew).Results:The two groups all showed statistically difference before and after treatment,decreased in NIH-CPSI score,subscore and IPSS(P0.05).There were no statistically differences between the two groups.Conclusion:Terazosin monotherapy for 8 weeks is effective for treating patients with CP/CPPS same as with diclofenac.

Key concepts: Terazosin, Medicine, Prostatitis, Diclofenac Sodium, Diclofenac, Urology, Internal medicine, Prostate

Related papers

Back to paper searchBrowse research topicsOriginal source
The Research of Terazosin Hydrochloride Combined with Diclofenac Sodium in Treatment of CP / CPPS — Research Paper | ScholarLens